Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Health Providers Seeking Drug Price Breaks Get HHS Review Boards

Dec. 10, 2020, 7:44 PM

Low-income health providers wanting to contain high medication costs can push for discounts through a resolution process the HHS released Thursday for disputing certain drug charges.

The long-awaited rule directs the Department of Health and Human Services to establish a 340B Administrative Dispute Resolution Board to review and resolve such disputes.

Drug companies have to sell medications to health centers that serve primarily low-income patients at steep discounts, commonly referred to as 340B discounts. Over the summer, drug companies cut back their discount programs, arguing certain pharmacies connected with 340B facilities weren’t statutorily owed lower prices.

The pharmacies argue they ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.